Geeta Gulati
- Cardiology and Cardiovascular Medicine top 2%
- Oncology top 10%
- Pulmonary and Respiratory Medicine top 10%
- Radiology, Nuclear Medicine and Imaging top 10%
- Molecular Biology
- Co-authors
- Torbjørn OmlandSiri Lagethon HeckJürgen GeislerKjetil SteineAnne Hansen ReeBerit GravdehaugHelge RøsjøPavel Hoffmann
- Topics
- Chemotherapy-induced cardiotoxicity and mitigation (14 papers)Cardiac Imaging and Diagnostics (8 papers)Cancer-related cognitive impairment studies (6 papers)
- Partner nations
- NorwayGermanyUnited Kingdom
In The Last Decade
Geeta Gulati
16 papers receiving 864 citations
Hit Papers
Peers
Comparison fields: 5 of 54
- Cardiology and Cardiovascular Medicine 800
- Oncology 398
- Pulmonary and Respiratory Medicine 247
- Radiology, Nuclear Medicine and Imaging 221
- Molecular Biology 68
Countries citing papers authored by Geeta Gulati
This map shows the geographic impact of Geeta Gulati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geeta Gulati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geeta Gulati more than expected).
Fields of papers citing papers by Geeta Gulati
This network shows the impact of papers produced by Geeta Gulati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geeta Gulati. The network helps show where Geeta Gulati may publish in the future.
Co-authorship network of co-authors of Geeta Gulati
This figure shows the co-authorship network connecting the top 25 collaborators of Geeta Gulati. A scholar is included among the top collaborators of Geeta Gulati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geeta Gulati. Geeta Gulati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 0 | |
| 4 | 16 | |
| 5 | 0 | |
| 6 | 80 | |
| 7 | 15 | |
| 8 | 87 | |
| 9 | 26 | |
| 10 | 41 | |
| 11 | 13 | |
| 12 | 29 | |
| 13 | 61 | |
| 14 | Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprololbreakdown → | 440 |
| 15 | 1 | |
| 16 | 38 | |
| 17 | 1 | |
| 18 | 28 |
About Geeta Gulati
Geeta Gulati is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Oncology, having authored 18 papers that have together received 879 indexed citations. Recurring topics across this work include Chemotherapy-induced cardiotoxicity and mitigation (14 papers), Cardiac Imaging and Diagnostics (8 papers) and Cancer-related cognitive impairment studies (6 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (800 citations), Oncology (398 citations) and Radiology, Nuclear Medicine and Imaging (221 citations). Geeta Gulati has collaborated with scholars based in Norway, Germany and United Kingdom. Frequent co-authors include Torbjørn Omland, Siri Lagethon Heck, Jürgen Geisler, Kjetil Steine, Anne Hansen Ree, Berit Gravdehaug, Helge Røsjø, Pavel Hoffmann, Jeanette Schulz‐Menger and Morten Wang Fagerland. Their work appears in journals such as Circulation, Cancer Research and European Heart Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.